Category: Pharmacotherapy
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Save the date: COVID-19 Sharing Facts, Not the Fear
March 3, 2020Quick review on COVID-19 from an ID Perspective
-
-
-
CardioPoint (7): Selecting appropriate NOAC
February 28, 2020A Brief Description on Practical Points in Anticoagulation
-
Predicting the Risk of Post-stroke Atrial Cardiopathy
February 27, 2020An interim analysis from ACARDIA trial
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Intensive LDL lowering beyond current recommendations for MACE prevention
February 12, 2020A meta-analysis of RCTs
-
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
February 3, 2020A meta-analysis of RCTs
-
-
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
January 21, 2020The findings of a recent study
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Intensive Blood Pressure lowering and the Concerns about Falling
January 18, 2020The findings of SPRINT trial
-
-
Cardiology Close-Up (10)
January 2, 2020Antithrombotic Therapy in Patients with Chronic Coronary Syndrome and in Sinus Rhythm
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
-
-
Case Discussion (1)
December 4, 2019Evidenced based discussion on routine cases of cardiology in clinical practice Appropriate OAC choice in AF
-
-
Inclisiran for patients with ASCVD and elevated LDL
December 2, 2019The findings of ORION-10 trial in ASCVD patients
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
November 29, 2019The findings of ORION-9 trial about Inclisiran in HeFH
-
The Efficacy and Safety of Low-Dose Colchicine after MI
November 29, 2019The findings of COLCOT trial about colchicine post-MI
-
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
November 29, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
November 29, 2019The findings of ISCHEMIA trial
-
Anti-ischemic Medications
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
November 12, 2019Rivaroxaban versus warfarin in APS
-
Antithrombotic treatment after CABG
November 12, 2019A recent meta-analysis on post-CABG Antithrombotic therapy
-
Triglyceride Lowering and Cardiovascular Risk Reduction
November 4, 2019A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
-
Guideline Made Easy
November 3, 2019Practical Guide for treatment of high blood cholesterol Part Three
-
-
Bedtime hypertension treatment improves cardiovascular risk reduction
October 29, 2019The findings of Hygia Chronotherapy Trial
-
Peri-operative beta-blockers in non-cardiac surgery
October 24, 2019The findings of Cochrane database systematic review
-
Daily Cardiology Cath-Conference: Case no. 2
October 23, 2019The second case of Daily Cardiology Cath-Conference
-
CardioPoint (5): NOACs in CKD
October 23, 2019A Brief Description on Practical Points in Anticoagulation
-
Cardiology Close-Up (7)
October 7, 2019Pharmacologic Therapy for LDL Cholesterol Treatment Goal and Pharmacologic Therapy for LDL Cholesterol
-
Insta Cath Conference (2) – Medical Management
October 4, 2019Expert discussion on complex and interesting angiograms
-
Guideline Made Easy
October 3, 2019Practical Guide for treatment of high blood cholesterol Part Two
-
Ticagrelor with or without Aspirin in High-Risk patients after PCI
September 28, 2019The findings of TWILIGHT Trial
-
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
September 20, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
AF Patients on NOACs Undergoing Elective PCI or Angiography: When to Hold?
September 3, 2019Pre-procedural management of DOACs
-
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
August 24, 2019The findings of COMPASS trial
-
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
August 20, 2019OACs in Stable CAD and AF
-
CardioPoint (3): NOACs in Elderly
August 19, 2019A Brief Description on Practical Points in Anticoagulation
-
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
August 3, 2019P2Y12 loading dose timing in PCI
-
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
July 9, 2019Preventing the cardiotoxicity of Trastuzumab
-
-
CardioPoint (2) – NOAC Monitoring, Do NOACs Need Monitoring?
June 19, 2019A Brief Description on Practical Points in Anticoagulation
-
Ezetimibe for the prevention of heart disease and death
June 14, 2019The role of Ezetimibe in reducing CVD adverse outcomes
-
-
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
May 29, 2019The findings of REASTART Trial
-
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
May 25, 2019DAPT after ischemic stroke or TIA
-
CardioPoint (1):Statins-Who is eligible?-Which dose?
May 19, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
-
-
-
Cardiology Close-Up (1)
March 7, 2019Management of Antithrombotic Therapy in AFib Patients Undergoing PCI
-
Case Discussion (26)
September 4, 2017The optimal duration of beta-blocker therapy after myocardial infarction
-
-
Case Discussion (8)
July 12, 2017An ignored challenge in HTN management: Non-dippers An evidence-based discussion
-
